(TREATMENT ONGOING) Since 4 May 2020, several COVID-19 positive patients, have commenced HBO therapy at Texas Medical Center’s Wound Care facility. These 7 patients were in a critical condition and...
(TREATMENT ONGOING) Since 4 May 2020, several COVID-19 positive patients, have commenced HBO therapy at Texas Medical Center’s Wound Care facility. These 7 patients were in a critical condition and...
(TRIAL ONGOING) This clinical trial, that commenced on 26 April 2020, is trialling HBOT-treatment for 30 COVID-19 positive patients hospitalized with moderate and severe symptoms including respiratory distress and at...
(TRIAL COMMENCING SHORTLY) This international clinical trial, estimated to commence on 8 May 2020, is in partnership with UCSD University of California San Diego and local hospitals. 200 COVID-19 positive...
(TRIAL ONGOING) This clinical trial, that commenced on 14 April 2020, is trialling HBOT-treatment for 100 COVID-19 positive patients who are oxygen-dependent with hypoxemic pneumonia. Participants are randomized into HBOT...
(TRIAL ONGOING) This clinical trial, that commenced on 1 April 2020, is trialling HBOT-treatment for 48 COVID-19 positive patients. Participants are randomized into HBOT treatment group vs control group. Both...
(TRIAL ONGOING) This non-randomized clinical study, that commenced on 6 April 2020, is trialling HBOT-treatment of 40 COVID-19 positive patients with respiratory distress. Each patient is receiving a 90-minute session...
This collection of 3 articles explore the trial’s overwhelming success as well as HBOT/COVID-19 protocol for ongoing treatment of COVID-19 patients: Rapid recovery of critically ill COVID-19 patients in ICU...
This collection of 3 articles explore the HBOT treatment and recovery of COVID-19 patients in Louisiana; with subsequent webinar discussion with the hospital’s doctors: HBOT RECOVERY OF 6 COVID-19 MEDICAL...
